Atlas Trials

Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer

Clinical trial NCT07166003 · RECRUITING

Trial details

NCT number
NCT07166003
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
RECRUITING
Study type
OBSERVATIONAL
Lung Cancer, Non-Small CellImmunotherapy
Start date
2025-04-20
Primary completion
2027-02-02
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.